3 Hospital Stocks With a Strong Future Roadmap: Apollo Hospitals, Max Healthcare and Fortis Healthcare
- October 6, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
Apollo Hospitals Rs 7,985.00, P/E 53.03. Max Healthcare Rs 917.00, P/E 61.23. Fortis Healthcare Rs 763.80, P/E 53.95. Closing prices of 5 Oct 2026.
Quick Answer
Hospital stocks with the clearest long-term roadmaps today include Apollo Hospitals in hospitals, pharmacy and digital health, Max Healthcare in premium hospitals and brownfield expansion and Fortis Healthcare in hospitals and diagnostics. FY26 revenue growth was 15.6% at Apollo Hospitals, 18.8% at Max Healthcare and 16.9% at Fortis Healthcare. P/E stands at 53.03 for Apollo Hospitals (industry 64.07), 61.23 for Max Healthcare (industry 64.07) and 53.95 for Fortis Healthcare (industry 64.07). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company’s risks need equal attention.
Hospital stocks give investors exposure to rising healthcare spending, as incomes grow and insurance penetration widens. Results depend on bed capacity, occupancy and average revenue per occupied bed, which is why expansion plans and case mix matter as much as headline growth.
This list covers three hospital sector stocks: Apollo Hospitals for hospitals, pharmacy and digital health, Max Healthcare for premium hospitals and brownfield expansion and Fortis Healthcare for hospitals and diagnostics. Every figure comes from the latest reported financials and the 5 October 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Hospital Stocks?
Hospital stocks are shares of companies that run multi-speciality hospitals and related services such as diagnostics and pharmacy. Their results depend on bed capacity, occupancy, the mix of treatments and insurance penetration, so brand strength and clinical quality drive pricing.
Hospital Stocks at a Glance
The table compares size, valuation, return on equity and debt for the three hospital stocks as of the 5 October 2026 close.
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE | Debt to Equity |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 7,985.00 | 1,15,172 | 53.03 | 64.07 | 20.48% | 0.90 |
| Max Healthcare | 917.00 | 89,214 | 61.23 | 64.07 | 13.42% | 0.32 |
| Fortis Healthcare | 763.80 | 57,754 | 53.95 | 64.07 | 10.53% | 0.35 |
Among hospital sector stocks, all three trade below their industry P/E multiples.
Why Do Hospital Stocks Have a Strong Roadmap in India?
Hospital stocks have a strong roadmap in India because rising incomes, wider insurance penetration and medical tourism push demand for quality hospital beds faster than supply grows. Three drivers stand out.
- Insurance penetration: More people with health cover use hospital care earlier, which lifts occupancy.
- Bed capacity and brownfield expansion: Adding beds at existing campuses costs less than new hospitals and lifts revenue quickly.
- Medical tourism: International patients add high-value procedures and raise average revenue per occupied bed.
Apollo Hospitals: Bed Capacity, Pharmacy and Digital Health Anchor the Roadmap
Apollo Hospitals’ roadmap rests on adding bed capacity in its hospital network, scaling its pharmacy and diagnostics businesses and growing its digital health platform.
Revenue grew from Rs 14,740.80 crore in FY22 to Rs 25,420.10 crore in FY26, a 72.4% rise, and FY26 revenue was 15.6% higher than FY25. FY26 net profit rose 33.1% to Rs 2,002.70 crore. Over four years, net profit rose from Rs 1,101.10 crore in FY22 to Rs 2,002.70 crore. In Q1 FY27, revenue grew 20.6% to Rs 7,092.30 crore, and net profit rose 38.4% to Rs 610.40 crore. Operating margin was 15.80% in FY26 and 16.39% in Q1 FY27 against 15.50% a year earlier.
Debt to equity is 0.90 and return on equity is 20.48%. FY26 operating cash flow was Rs 2,855.70 crore against capital expenditure of Rs 1,962.00 crore. Apollo Hospitals paid a dividend of Rs 20 per share for FY26, a yield of 0.25%. At a P/E of 53.03 against an industry P/E of 64.07, the stock trades below its industry multiple.
What to watch: FY26 capital expenditure of Rs 1,962.00 crore reflects the expansion plan. Debt to equity of 0.90 deserves tracking.
Max Healthcare: Brownfield Expansion and Higher Revenue Per Bed Drive the Pipeline
Max Healthcare’s roadmap rests on brownfield expansion at its existing hospitals, new hospitals in its core regions and higher average revenue per occupied bed.
Revenue grew from Rs 4,058.82 crore in FY22 to Rs 8,536.07 crore in FY26, a 110.3% rise, and FY26 revenue was 18.8% higher than FY25. FY26 net profit rose 34.1% to Rs 1,442.41 crore. Over four years, net profit rose from Rs 605.05 crore in FY22 to Rs 1,442.41 crore. In Q1 FY27, revenue grew 16.6% to Rs 2,406.69 crore, and net profit rose 4.9% to Rs 322.96 crore. Operating margin was 28.15% in FY26 and 27.00% in Q1 FY27 against 27.59% a year earlier.
Debt to equity is 0.32 and return on equity is 13.42%. FY26 operating cash flow was Rs 1,633.32 crore against capital expenditure of Rs 1,484.53 crore. Max Healthcare paid a dividend of Rs 2 per share for FY26, a yield of 0.22%. At a P/E of 61.23 against an industry P/E of 64.07, the stock trades below its industry multiple.
What to watch: Capital expenditure of Rs 1,484.53 crore in FY26 absorbed most of operating cash flow of Rs 1,633.32 crore, and Q1 FY27 operating margin of 27.00% was below the 27.59% of Q1 FY26.
Fortis Healthcare: Occupancy, Beds and Diagnostics Build the Next Leg
Fortis Healthcare’s roadmap rests on adding beds across its hospital network, higher occupancy and a diagnostics business that adds a second revenue line.
Revenue grew from Rs 5,744.95 crore in FY22 to Rs 9,178.50 crore in FY26, a 59.8% rise, and FY26 revenue was 16.9% higher than FY25. FY26 net profit rose 31.5% to Rs 1,064.19 crore. Over four years, net profit rose from Rs 789.95 crore in FY22 to Rs 1,064.19 crore. In Q1 FY27, revenue grew 17.3% to Rs 2,559.50 crore, and net profit rose 2.3% to Rs 272.80 crore. Operating margin was 22.41% in FY26 and 22.22% in Q1 FY27 against 24.07% a year earlier.
Debt to equity is 0.35 and return on equity is 10.53%. FY26 operating cash flow was Rs 1,601.45 crore against capital expenditure of Rs 945.44 crore. Fortis Healthcare paid a dividend of Rs 1 per share for FY26, a yield of 0.13%. At a P/E of 53.95 against an industry P/E of 64.07, the stock trades below its industry multiple.
What to watch: Return on equity of 10.53% is the lowest of the three, and Q1 FY27 operating margin of 22.22% was below the 24.07% of Q1 FY26.
Best Hospital Stocks in India: Apollo Hospitals vs Max Healthcare vs Fortis Healthcare on Key Financials
Among the best hospital stocks in India, Max Healthcare leads on FY26 operating margin and five-year revenue growth; Apollo Hospitals leads on Q1 FY27 revenue growth and return on equity. The table puts the numbers side by side.
| Metric | Apollo Hospitals | Max Healthcare | Fortis Healthcare |
|---|---|---|---|
| FY26 revenue (Rs Cr) | 25,420.10 | 8,536.07 | 9,178.50 |
| FY26 revenue growth | 15.6% | 18.8% | 16.9% |
| Revenue growth FY22 to FY26 | 72.4% | 110.3% | 59.8% |
| FY26 net profit (Rs Cr) | 2,002.70 | 1,442.41 | 1,064.19 |
| FY26 net profit growth | 33.1% | 34.1% | 31.5% |
| FY26 operating profit margin | 15.80% | 28.15% | 22.41% |
| Q1 FY27 revenue growth (YoY) | 20.6% | 16.6% | 17.3% |
| Q1 FY27 net profit growth (YoY) | 38.4% | 4.9% | 2.3% |
| Return on equity | 20.48% | 13.42% | 10.53% |
| P/E ratio | 53.03 | 61.23 | 53.95 |
| Debt to equity | 0.90 | 0.32 | 0.35 |
| Dividend yield | 0.25% | 0.22% | 0.13% |
| FY26 operating cash flow (Rs Cr) | 2,855.70 | 1,633.32 | 1,601.45 |
Hospital revenue builds steadily through the year, so quarterly growth gives a fair read of occupancy and pricing trends.
How to Evaluate Healthcare Stocks to Buy Before You Invest
A short checklist keeps the research consistent when you screen hospital stocks and shortlist healthcare stocks to buy.
- Compare each stock’s P/E with its industry P/E, which is 64.07 for all three here.
- Track operating margin across several quarters, because input costs can move faster than prices.
- Check whether revenue growth is turning into profit growth, not only sales.
- Read operating cash flow against capital expenditure to see how growth is funded.
- Watch debt to equity and interest cover before sizing a position.
- Spread exposure across companies and business lines instead of one demand cycle.
Check the Univest Screener for live data on these hospital stocks
Risks to Consider Before Investing in Hospital Stocks
- Pricing and regulation: Caps on procedure prices or insurer negotiations can limit revenue per bed.
- Valuation: The three stocks trade at 53.03 to 61.23 times earnings, against an industry multiple of 64.07, so a miss on occupancy can weigh on them.
- Capital intensity: New beds need heavy spending, and returns depend on occupancy ramping up.
- Talent costs: Doctor and nursing costs rise with demand and can squeeze operating margin.
Download the Univest iOS App or Univest Android App to track Apollo Hospitals, Max Healthcare and Fortis Healthcare live.
Final Take: Which Stock Has the Strongest Roadmap?
These three healthcare stocks cover hospitals with pharmacy and digital health, premium brownfield expansion, and hospitals with diagnostics. Max Healthcare leads on FY26 operating margin and five-year revenue growth; Apollo Hospitals leads on Q1 FY27 revenue growth and return on equity.
Across hospital sector stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the healthcare stocks to buy discussed here.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Hospital Stocks
Which are the best hospital stocks in India with a strong roadmap?
Ans. Apollo Hospitals, Max Healthcare and Fortis Healthcare stand out for their roadmaps in hospitals, bed capacity and diagnostics. FY26 revenue growth was 15.6% at Apollo Hospitals, 18.8% at Max Healthcare and 16.9% at Fortis Healthcare, and return on equity ranges from 10.53% to 20.48%.
Is Apollo Hospitals a good stock to buy now?
Ans. Apollo Hospitals has a debt to equity ratio of 0.90, a return on equity of 20.48% and a P/E of 53.03 against an industry P/E of 64.07. Occupancy, pricing and the cost of new capacity move results, even though the stock trades below its industry multiple. This article is not investment advice, so consult a SEBI-registered advisor before deciding.
What is the P/E ratio of Apollo Hospitals, Max Healthcare and Fortis Healthcare?
Ans. The P/E ratio is 53.03 for Apollo Hospitals (industry 64.07), 61.23 for Max Healthcare (industry 64.07) and 53.95 for Fortis Healthcare (industry 64.07). All three trade below the industry multiple.
Which of these hospital stocks has the highest return on equity?
Ans. Apollo Hospitals has the highest return on equity at 20.48%, followed by Max Healthcare at 13.42% and Fortis Healthcare at 10.53%.
What are the risks of investing in hospital stocks?
Ans. The main risks are price caps and insurer negotiations, the cost of building new beds, rising doctor and nursing costs and valuation. The three stocks trade at 53.03 to 61.23 times earnings against an industry multiple of 64.07.
How did Apollo Hospitals, Max Healthcare and Fortis Healthcare perform in Q1 FY27?
Ans. Apollo Hospitals reported revenue of Rs 7,092.30 crore, up 20.6% year on year, and net profit rose 38.4% to Rs 610.40 crore. Max Healthcare reported revenue of Rs 2,406.69 crore, up 16.6% year on year, and net profit rose 4.9% to Rs 322.96 crore. Fortis Healthcare reported revenue of Rs 2,559.50 crore, up 17.3% year on year, and net profit rose 2.3% to Rs 272.80 crore.
Do hospital stocks pay dividends?
Ans. Yes, all three companies pay dividends. The dividend yield is 0.25% for Apollo Hospitals, 0.22% for Max Healthcare and 0.13% for Fortis Healthcare, based on dividends declared for FY26.
How can I invest in hospital stocks in India?
Ans. You can buy hospital stocks through a demat and trading account on NSE or BSE after checking each company’s financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.
